2024 Ash Meeting Abstracts Examples. Disease burden and minimal residual disease in prognosis and treatment: Affimed announces acceptance of three abstracts at the 2024 ash annual meeting including an oral presentation underscoring advancing clinical pipeline in leukemia.
Joseph mikhael, and members of. Measurable residual disease in aml in 2024 and beyond 621.